BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35434302)

  • 41.
    Kashiki H; Li H; Miyamoto S; Ueno H; Tsurusaki Y; Ikeda C; Kurata H; Okada T; Shimazu T; Imamura H; Enomoto Y; Takanashi JI; Kurosawa K; Saitsu H; Inoue K
    Neurol Genet; 2020 Dec; 6(6):e524. PubMed ID: 33134519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. POLR3-related leukodystrophy caused by biallelic
    Liu J; Niu Y; Qin J; Yang Z
    Front Neurol; 2024; 15():1355484. PubMed ID: 38550343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Next-Generation Sequencing Reveals Novel Homozygous Missense Variant c.934T > C in
    Naseer MI; Abdulkareem AA; Pushparaj PN; Saharti S; Muthaffar OY
    Front Pediatr; 2022; 10():862722. PubMed ID: 35685919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Chinese patient with
    Sun L; Lin W; Meng H; Zhang W; Hou S
    Front Neurol; 2023; 14():1269237. PubMed ID: 37965164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A).
    Casamassa A; Rotundo G; Ceresoni C; Turco EM; Torrente I; Candido O; Nicita F; Tonduti D; Bertini E; Marano M; Ferrari D; Cereda C; Pennuto M; Vescovi AL; Carelli S; Rosati J
    Stem Cell Res; 2024 Aug; 78():103468. PubMed ID: 38852424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical spectrum of POLR3-related leukodystrophy caused by biallelic
    Gauquelin L; Cayami FK; Sztriha L; Yoon G; Tran LT; Guerrero K; Hocke F; van Spaendonk RML; Fung EL; D'Arrigo S; Vasco G; Thiffault I; Niyazov DM; Person R; Lewis KS; Wassmer E; Prescott T; Fallon P; McEntagart M; Rankin J; Webster R; Philippi H; van de Warrenburg B; Timmann D; Dixit A; Searle C; ; Thakur N; Kruer MC; Sharma S; Vanderver A; Tonduti D; van der Knaap MS; Bertini E; Goizet C; Fribourg S; Wolf NI; Bernard G
    Neurol Genet; 2019 Dec; 5(6):e369. PubMed ID: 32042905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. POLR3A and POLR3B Mutations in Unclassified Hypomyelination.
    Cayami FK; La Piana R; van Spaendonk RM; Nickel M; Bley A; Guerrero K; Tran LT; van der Knaap MS; Bernard G; Wolf NI
    Neuropediatrics; 2015 Jun; 46(3):221-8. PubMed ID: 26011300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Teaching neuroimages: hypomyelinating leukodystrophy with hypodontia due to POLR3B: look into a leukodystrophy's mouth.
    Synofzik M; Bernard G; Lindig T; Gburek-Augustat J
    Neurology; 2013 Nov; 81(19):e145. PubMed ID: 24190003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional characterization of Polr3a hypomyelinating leukodystrophy mutations in the S. cerevisiae homolog, RPC160.
    Moir RD; Lavados C; Lee J; Willis IM
    Gene; 2021 Feb; 768():145259. PubMed ID: 33148458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dystonia in RNA Polymerase III-Related Leukodystrophy.
    Al Yazidi G; Tran LT; Guerrero K; Vanderver A; Schiffmann R; Wolf NI; Chouinard S; Bernard G
    Mov Disord Clin Pract; 2019 Feb; 6(2):155-159. PubMed ID: 30838315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel POLR3A genotype leads to leukodystrophy type-7 in two siblings with unusually late age of onset.
    Campopiano R; Ferese R; Zampatti S; Giardina E; Biagioni F; Colonnese C; Centonze D; Storto M; Buttari F; Fraviga E; Broccoli V; Fanelli M; Fornai F; Gambardella S
    BMC Neurol; 2020 Jun; 20(1):258. PubMed ID: 32600288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neonatal progeriod syndrome associated with biallelic truncating variants in POLR3A.
    Jay AM; Conway RL; Thiffault I; Saunders C; Farrow E; Adams J; Toriello HV
    Am J Med Genet A; 2016 Dec; 170(12):3343-3346. PubMed ID: 27612211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 4H syndrome with late-onset growth hormone deficiency caused by POLR3A mutations.
    Potic A; Brais B; Choquet K; Schiffmann R; Bernard G
    Arch Neurol; 2012 Jul; 69(7):920-3. PubMed ID: 22451160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel mutation in GJC2 associated with hypomyelinating leukodystrophy type 2 disorder.
    Komachali SR; Sheikholeslami M; Salehi M
    Genomics Inform; 2022 Jun; 20(2):e24. PubMed ID: 35794704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathy.
    Djordjevic D; Pinard M; Gauthier MS; Smith-Hicks C; Hoffman TL; Wolf NI; Oegema R; van Binsbergen E; Baskin B; Bernard G; Fribourg S; Coulombe B; Yoon G
    Am J Hum Genet; 2021 Jan; 108(1):186-193. PubMed ID: 33417887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biallelic variants in POLR3GL cause endosteal hyperostosis and oligodontia.
    Terhal PA; Vlaar JM; Middelkamp S; Nievelstein RAJ; Nikkels PGJ; Ross J; Créton M; Bos JW; Voskuil-Kerkhof ESM; Cuppen E; Knoers N; van Gassen KLI
    Eur J Hum Genet; 2020 Jan; 28(1):31-39. PubMed ID: 31089205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biallelic mutations in the homeodomain of NKX6-2 underlie a severe hypomyelinating leukodystrophy.
    Dorboz I; Aiello C; Simons C; Stone RT; Niceta M; Elmaleh M; Abuawad M; Doummar D; Bruselles A; Wolf NI; Travaglini L; Boespflug-Tanguy O; Tartaglia M; Vanderver A; Rodriguez D; Bertini E
    Brain; 2017 Oct; 140(10):2550-2556. PubMed ID: 28969374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 4H Leukodystrophy: Lessons from 3T Imaging.
    Cayami FK; Bugiani M; Pouwels PJW; Bernard G; van der Knaap MS; Wolf NI
    Neuropediatrics; 2018 Apr; 49(2):112-117. PubMed ID: 29179231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Case Report: Severe Osteoporosis and Preventive Therapy in RNA Polymerase III-Related Leukodystrophy.
    Furukawa S; Kunii M; Doi H; Kondo N; Ogura A; Hirabuki K; Itoh T; Matsumoto N; Tanaka F; Katsuno M; Ito Y
    Front Neurol; 2021; 12():622355. PubMed ID: 33716926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. POLR3-Related Leukodystrophy: Exploring Potential Therapeutic Approaches.
    Perrier S; Michell-Robinson MA; Bernard G
    Front Cell Neurosci; 2020; 14():631802. PubMed ID: 33633543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.